These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 30744559)

  • 1. Plasma levels of TNF-α, IL-6, IFN-γ, IL-12, IL-17, IL-22, and IL-23 in achalasia, eosinophilic esophagitis (EoE), and gastroesophageal reflux disease (GERD).
    Clayton S; Cauble E; Kumar A; Patil N; Ledford D; Kolliputi N; Lopes-Virella MF; Castell D; Richter J
    BMC Gastroenterol; 2019 Feb; 19(1):28. PubMed ID: 30744559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of a Noninvasive Serum Biomarker Panel for Diagnosis and Monitoring of Eosinophilic Esophagitis: A Prospective Study.
    Dellon ES; Rusin S; Gebhart JH; Covey S; Higgins LL; Beitia R; Speck O; Woodward K; Woosley JT; Shaheen NJ
    Am J Gastroenterol; 2015 Jun; 110(6):821-7. PubMed ID: 25781367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Esophagoprotective activity of angiotensin-(1-7) in experimental model of acute reflux esophagitis. Evidence for the role of nitric oxide, sensory nerves, hypoxia-inducible factor-1alpha and proinflammatory cytokines.
    Pawlik MW; Kwiecien S; Pajdo R; Ptak-Belowska A; Brzozowski B; Krzysiek-Maczka G; Strzalka M; Konturek SJ; Brzozowski T
    J Physiol Pharmacol; 2014 Dec; 65(6):809-22. PubMed ID: 25554985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pattern of esophageal eosinophilic infiltration in patients with achalasia and response to Heller myotomy and Dor fundoplication.
    Cools-Lartigue J; Chang SY; Mckendy K; Mayrand S; Marcus V; Fried GM; Ferri LE
    Dis Esophagus; 2013; 26(8):766-75. PubMed ID: 22891632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased number of regulatory T cells in esophageal tissue of patients with eosinophilic esophagitis in comparison to gastro esophageal reflux disease and control groups.
    Mousavinasab F; Babaie D; Nilipour Y; Mansouri M; Imanzadeh F; Dara N; Rohani P; Khatami K; Sayyari A; Khoddami M; Kazemiaghdam M; Mesdaghi M
    Allergol Immunopathol (Madr); 2019; 47(5):431-436. PubMed ID: 31178311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can esophageal symptoms be associated with sleep disorders in esophageal rare diseases?. A prospective case-control study across achalasia, eosinophilic esophagitis and gastroesophageal reflux disease.
    Gagliardi M; Iovino P; Gargano D; Zulli C; Fortino L; Santonicola A
    Minerva Gastroenterol (Torino); 2023 Sep; 69(3):365-373. PubMed ID: 37642600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of esophageal body peristaltic work using functional lumen imaging probe panometry.
    Acharya S; Halder S; Carlson DA; Kou W; Kahrilas PJ; Pandolfino JE; Patankar NA
    Am J Physiol Gastrointest Liver Physiol; 2021 Feb; 320(2):G217-G226. PubMed ID: 33174457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conserved IFN Signature between Adult and Pediatric Eosinophilic Esophagitis.
    Ruffner MA; Hu A; Dilollo J; Benocek K; Shows D; Gluck M; Spergel JM; Ziegler SF; Hill DA; Cerosaletti K
    J Immunol; 2021 Mar; 206(6):1361-1371. PubMed ID: 33558373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of inducible nitric oxide synthase, nitrotyrosine, eosinophilic peroxidase, eotaxin-3, and galectin-3 in patients with gastroesophageal reflux disease, eosinophilic esophagitis, and in healthy controls: a semiquantitative image analysis of 3,3'-diaminobenzidine-stained esophageal biopsies.
    Plate J; Bove M; Larsson HM; Norder Grusell E; Chatterjee N; Johansson LE; Bergquist H
    Dis Esophagus; 2024 Aug; 37(9):. PubMed ID: 38679488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Markers of antigen presentation and activation on eosinophils and T cells in the esophageal tissue of patients with eosinophilic esophagitis.
    Le-Carlson M; Seki S; Abarbanel D; Quiros A; Cox K; Nadeau KC
    J Pediatr Gastroenterol Nutr; 2013 Mar; 56(3):257-62. PubMed ID: 23059644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Prospective Study of Eosinophilic Esophagitis and the Expression of Tight Junction Proteins in Patients with Gastroesophageal Reflux Disease Symptoms.
    Okimoto K; Arai M; Ishigami H; Saito K; Minemura S; Maruoka D; Matsumura T; Nakagawa T; Katsuno T; Suzuki M; Nakatani Y; Yokosuka O
    Gut Liver; 2018 Jan; 12(1):30-37. PubMed ID: 29032661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgG4 is Elevated in Eosinophilic Esophagitis but Not in Gastroesophageal Reflux Disease Patients.
    Weidlich S; Nennstiel S; Jesinghaus M; Brockow K; Slotta-Huspenina J; Bajbouj M; Schmid RM; Schlag C
    J Clin Gastroenterol; 2020 Jan; 54(1):43-49. PubMed ID: 30614939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
    Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
    Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can Eosinophilic Esophagitis Cause Achalasia and Other Esophageal Motility Disorders?
    Spechler SJ; Konda V; Souza R
    Am J Gastroenterol; 2018 Nov; 113(11):1594-1599. PubMed ID: 30315308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features distinguish eosinophilic and reflux-induced esophagitis.
    Mulder DJ; Hurlbut DJ; Noble AJ; Justinich CJ
    J Pediatr Gastroenterol Nutr; 2013 Mar; 56(3):263-70. PubMed ID: 23085895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nutritional State and Feeding Behaviors of Children With Eosinophilic Esophagitis and Gastroesophageal Reflux Disease.
    Mehta P; Furuta GT; Brennan T; Henry ML; Maune NC; Sundaram SS; Menard-Katcher C; Atkins D; Takurukura F; Giffen S; Pan Z; Haas AM
    J Pediatr Gastroenterol Nutr; 2018 Apr; 66(4):603-608. PubMed ID: 28906318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon γ-Induced Nuclear Interleukin-33 Potentiates the Release of Esophageal Epithelial Derived Cytokines.
    Shan J; Oshima T; Wu L; Fukui H; Watari J; Miwa H
    PLoS One; 2016; 11(3):e0151701. PubMed ID: 26986625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Esophageal diseases: GERD, Barrett, achalasia and eosinophilic esophagitis].
    Calvet X; Villoria A
    Gastroenterol Hepatol; 2014 Sep; 37 Suppl 3():53-61. PubMed ID: 25294266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cultivable bacterial flora of the esophagus in subjects with esophagitis.
    Norder Grusell E; Dahlén G; Ruth M; Bergquist H; Bove M
    Scand J Gastroenterol; 2018 Jun; 53(6):650-656. PubMed ID: 29616839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity.
    Talaat RM; Mohamed SF; Bassyouni IH; Raouf AA
    Cytokine; 2015 Apr; 72(2):146-53. PubMed ID: 25647269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.